Bilirubin encephalopathy is a rare neurological condition that occurs in some newborns with severe jaundice.

Bilirubin-induced neurologic dysfunction (BIND); Kernicterus

Bilirubin encephalopathy (BE) is caused by very high levels of bilirubin in the blood and body. Bilirubin is a yellow pigment that is created as the body gets rid of old red blood cells. High levels of bilirubin in the body can cause the skin to look yellow (jaundice).

If the level of bilirubin in the blood is very high or a baby is very ill, the substance will move out of the blood and collect in the brain tissue if it is not bound to albumin (protein) in the blood. This can lead to problems such as brain damage and hearing loss. The term "kernicterus" refers to the yellow staining caused by bilirubin. This is seen in parts of the brain on autopsy.

This condition most often develops in the first week of life, but may be seen up until the third week. Some newborns with Rh hemolytic disease are at high risk for severe jaundice that can lead to this condition. Rarely, BE can develop in seemingly healthy babies.

The symptoms depend on the stage of BE. Not all babies with kernicterus on autopsy have had definite symptoms.

Early stage:

• Extreme jaundice
• Absent startle reflex
• Poor feeding or sucking
• Extreme sleepiness (lethargy) and low muscle tone (hypotonia)

Middle stage:

• High-pitched cry
• Irritability
• May have arched back with neck hyperextended backwards, high muscle tone (hypertonia)
• Poor feeding

Late stage:

• Stupor or coma
• No feeding
• Shrill cry
• Muscle rigidity, markedly arched back with neck hyperextended backwards
• Seizures

Treatment depends on how old the baby is (in hours) and whether the baby has any risk factors (such as prematurity). It may include:

• Light therapy (phototherapy)
• Exchange transfusions (removing the child's blood and replacing it with fresh donor blood or plasma)

BE is a serious condition. Many infants with nervous system complications die.

Complications may include:

• Permanent brain damage
• Hearing loss
• Death

Get medical help right away if your baby has signs of this condition.

Treating jaundice or conditions that may lead to it can help prevent this problem. Infants with the first signs of jaundice have their bilirubin level measured within 24 hours. If the level is high, the infant should be screened for diseases that involve the destruction of red blood cells (hemolysis).

All newborns should have a follow-up appointment within 2 to 3 days after leaving the hospital. This is very important for late preterm or early term babies (born more than 2 to 3 weeks before their due date).

Published Date: April 05, 2025
Published By: Charles I. Schwartz, MD, FAAP, Clinical Assistant Professor of Pediatrics, Perelman School of Medicine at the University of Pennsylvania, General Pediatrician at PennCare for Kids, Phoenixville, PA. Also reviewed by David C. Dugdale, MD, Medical Director, Brenda Conaway, Editorial Director, and the A.D.A.M. Editorial team.

Hamati AI, Felker MV. Neurological complications of systemic disease: children. In: Jankovic J, Mazziotta JC, Pomeroy SL, Newman NJ, eds. Bradley and Daroff's Neurology in Clinical Practice. 8th ed. Philadelphia, PA: Elsevier; 2022:chap 59.

Hansen TWR. Pathophysiology of kernicterus. In: Polin RA, Abman SH, Rowitch DH, Benitz WE, Fox WW, eds. Fetal and Neonatal Physiology. 6th ed. Philadelphia, PA: Elsevier; 2022:chap 163.

Kaplan M, Wong RJ, Bensen R, Sibley E, Stevenson DK. Neonatal jaundice and liver disease. In: Martin RJ, Fanaroff AA, eds. Fanaroff and Martin's Neonatal-Perinatal Medicine. 12th ed. Philadelphia, PA: Elsevier; 2025:chap 95.

Ryan KS, Kliegman RM. Jaundice and hyperbilirubinemia in the newborn. In: Kliegman RM, St. Geme JW, Blum NJ, et al, eds. Nelson Textbook of Pediatrics. 22nd ed. Philadelphia, PA: Elsevier; 2025:chap 137.